AiCure
AiCure's platform uses computer vision and smartphone-captured data to monitor medication adherence, patient behavior and digital biomarkers during clinical trials. It serves life-sciences and pharma sponsors, and reports more than 84 issued patents. Founded in 2010 and initially funded by NIH grants, the company has raised roughly $50–77M across sources, including a $16M later-stage round in January 2024.
Funding
Every round, secondary, debt facility or acquisition involving AiCure that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see every AI company on Lounge with revenue, funding, valuation and investors, searchable and sortable, plus CSV exports. Plans start at $19/mo.
See plans →Log in